Despite the central roles of CHK1 and the observation that faithful DNA replication and DNA repair processes are often disrupted in rapidly dividing tumor cells,[1] the therapeutic potential of CHK1 in cancer has not been realized with the known CHK1 inhibitors to date. This evidence concerns the gene CHEK1 and cancer.